Reputation and Power
Organizational Image and Pharmaceutical Regulation at the FDA
Published on 2. May 2010
Book
Hardback
856 pages
978-0-691-14179-4 (ISBN)
Description
The U.S. Food and Drug Administration is the most powerful regulatory agency in the world. How did the FDA become so influential? And how exactly does it wield its extraordinary power? "Reputation and Power" traces the history of FDA regulation of pharmaceuticals, revealing how the agency's organizational reputation has been the primary source of its power, yet also one of its ultimate constraints. Daniel Carpenter describes how the FDA cultivated a reputation for competence and vigilance throughout the last century, and how this organizational image has enabled the agency to regulate an industry as powerful as American pharmaceuticals while resisting efforts to curb its own authority. Carpenter explains how the FDA's reputation and power have played out among committees in Congress, and with drug companies, advocacy groups, the media, research hospitals and universities, and governments in Europe and India. He shows how FDA regulatory power has influenced the way that business, medicine, and science are conducted in the United States and worldwide.
Along the way, Carpenter offers new insights into the therapeutic revolution of the 1940s and 1950s; the 1980s AIDS crisis; the advent of oral contraceptives and cancer chemotherapy; the rise of antiregulatory conservatism; and the FDA's waning influence in drug regulation today. "Reputation and Power" demonstrates how reputation shapes the power and behavior of government agencies, and sheds new light on how that power is used and contested.
Along the way, Carpenter offers new insights into the therapeutic revolution of the 1940s and 1950s; the 1980s AIDS crisis; the advent of oral contraceptives and cancer chemotherapy; the rise of antiregulatory conservatism; and the FDA's waning influence in drug regulation today. "Reputation and Power" demonstrates how reputation shapes the power and behavior of government agencies, and sheds new light on how that power is used and contested.
Reviews / Votes
Reputation and Power is ... and authoritative and well researched book. Political scientists will admire Carpenter's scholarship. It is, indeed, a good mix of history, politics, gossip, and intrigue. -- Michael Rawlins Lancet In his massive, magisterial Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA, the Harvard political scientist Daniel Carpenter provides both a history of the agency and an analysis of how it gained and flexed its most important regulatory power, the ability to keep new drugs off the market. Carpenter carefully documents the ways FDA bureaucrats have worked to exploit opportunities to expand their influence and reshape how the drug industry and the medical profession operate. -- Keith E. Wittington Reason This immense volume considers the Food and Drug Administration's regulation of the pharmaceutical industry, focusing on the connection between the FDA's stellar reputation and its ability to wield power as a regulatory body. The book is exceptional, successfully combining an array of methodological approaches. Choice Carpenter's book has much to offer. Reputation and Power will be a valuable resource for anyone who is interested in understanding US pharmaceutical regulation and the debates surrounding it. -- Mary K. Olson Health Affairs This book succeeds quite well in achieving its ambitious objectives. It provides a compelling and useful account for the exceptional role of the FDA in American society, government, and regulation. Perhaps more importantly for organizational scholars, it provides a very rich case study of the evolution of an organization's reputation, image and power and how these combine to affect its performance. -- Thomas D'Aunno Administrative Science Quarterly Carpenter's book was ten years in the making and it shows. The research is wide ranging and groundbreaking and the impressive range of materials will certainly help expand the field... Reputation and Power is essential reading for modern historians of medicine. In a renewed climate of interest in regulation, it is a sober addition to the previous polemical debates about the world of pharmaceuticals and their regulation and is sure to generate a broad discussion. -- Lucas Richert Social History of Medicine Reputation and Power ... is a masterful study in the best tradition of political science and will stand as a definitive treatment of regulation, and not merely of the FDA's policies and practices. Along with his earlier work, this book will be an essential part of the emerging study of the American administrative state, whether that study takes place in political science, history, sociology, law, or, indeed, in schools of medicine and pharmacology. -- John Ferejohn Perspectives on PoliticsMore details
Series
Language
English
Place of publication
New Jersey
United States
Target group
College/higher education
Professional and scholarly
Product notice
Trade binding
Illustrations
13 halftones. 17 line illus. 13 tables.
Dimensions
Height: 229 mm
Width: 152 mm
Weight
1304 gr
ISBN-13
978-0-691-14179-4 (9780691141794)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
Book
05/2010
Princeton University Press
€54.60
Article not available at the moment
Person
Daniel P. Carpenter is the Allie S. Freed Professor of Government at Harvard University. He is the author of "The Forging of Bureaucratic Autonomy: Reputations, Networks, and Policy Innovation in Executive Agencies, 1862-1928" (Princeton).
Content
LIST OF ILLUSTRATIONS ix LIST OF TABLES xi ACKNOWLEDGMENTS xiii LIST OF ABBREVIATIONS AND ACRONYMS xvii INTRODUCTION: The Gatekeeper 1 CHAPTER ONE: Reputation and Regulatory Power 33 PART ONE: ORGANIZATIONAL EMPOWERMENT AND CHALLENGE CHAPTER TWO: Reputation and Gatekeeping Authority: The Federal Food, Drug and Cosmetic Act of 1938 and Its Aftermath 73 CHAPTER THREE: The Ambiguous Emergence of American Pharmaceutical Regulation, 1944-1961 118 CHAPTER FOUR: Reputation and Power Crystallized: Thalidomide, Frances Kelsey, and Phased Experiment, 1961-1966 228 CHAPTER FIVE: Reputation and Power Institutionalized: Scientific Networks, Congressional Hearings, and Judicial Affirmation, 1963-1986 298 CHAPTER SIX: Reputation and Power Contested: Emboldened Audiences in Cancer and AIDS, 1977-1992 393 PART TWO: PHARMACEUTICAL REGULATION AND ITS AUDIENCES CHAPTER SEVEN: Reputation and the Organizational Politics of New Drug Review 465 CHAPTER EIGHT: The Governance of Research and Development: Gatekeeping Power, Conceptual Guidance, and Regulation by Satellite 544 CHAPTER NINE: The Other Side of the Gate: Reputation, Power, and Post-Market Regulation 585 CHAPTER TEN: The D?tente of Firm and Regulator 635 CHAPTER ELEVEN: American Pharmaceutical Regulation in International Context: Audiences, Comparisons, and Dependencies 686 CHAPTER TWELVE: Conclusion: A Reputation in Relief 727 PRIMARY SOURCES AND ARCHIVAL COLLECTIONS 753 INDEX 759